期刊文献+

Apo B和Apo AⅠ/Apo B比值在家族性高胆固醇血症与家族性混合型高脂血症鉴别诊断中的作用 被引量:2

Value of Apo B and ratio of Apo AⅠ/ Apo B in differential diagnosis between familial hypercholesterolemia and familial combined hyperlipidemia
在线阅读 下载PDF
导出
摘要 目的分析家族性高胆固醇血症(FH)家系与家族性混合型高脂血症(FCHL)家系成员之间血脂水平及肾功能指标的差异,探寻用于FH和FCHL鉴别诊断的指标。方法收集符合诊断标准的FH家系6个(共47人),FCHL家系23个(共94人),正常对照组家系10个(共57人),在FH家系和FCHL家系内又分为血脂升高的受累组和血脂正常的未受累组,比较各组之间的血脂水平和肾功能指标(包括CO2CP、BUN、Cr、BUN/Cr、UA)。结果 FH家系受累组TC、HDL-C、LDL-C及Apo B水平均明显高于未受累组和对照组,Apo AⅠ/Apo B比值明显低于未受累组和对照组,LP(a)、BUN和Cr水平也高于未受累组和对照组,TAG水平高于未受累组和对照组,差异均有统计学意义。FCHL家系受累组TC、TAG、LDL-C及Apo B水平均明显高于未受累组和对照组,HDL-C水平高于未受累组和对照组,Apo AⅠ/Apo B比值明显低于未受累组和对照组,LP(a)和BUN水平也高于对照组,差异均有统计学意义。2个家系受累组间相比,FH家系LDL-C和Apo B水平明显高于FCHL家系,TC水平和Apo AⅠ/Apo B比值也高于FCHL家系,而TAG水平明显低于FCHL家系。结论除常用的TC、TAG和LDL-C之外,Apo B和Apo AⅠ/Apo B有望成为FH与FCHL鉴别诊断的指标。 Objective To analyze the differences in lipid levels and renal function indexes between family m em bers with familial hypercholesterolem ia( FH) and familial com bined hyperlipidem ia( FC H L) and investigate indexes that m ay be used for the differential diagnosis between FH and FC H L. Methods Six FH pedigrees( 47 persons) and 23 FC H L pedigrees( 94 persons) that m et the diagnosis criteria and 10 norm al control pedigrees( 57 persons) were recruited. Persons in FH and FC H L pedigrees were assigned to the affected groups with elevated blood lipid levels and the non-affected groups with normal blood lipid levels. Blood lipid levels and renal function indexes( including CO_2 C P, BU N,Cr,BU N / Cr, and UA) were com pared betw een groups.Results The affected group in FH pedigrees had remarkably higher levels of TC, H D L-C, LD L-C, and Apo B, rem arkably low er level of Apo AⅠ/Apo B, and higher levels of LP( a), BUN, Cr, and TAG as com pared with the non-affected group and the control group. The differences were statistically significant. The affected group in FCH L pedigrees had remarkably higher levels of TC,TAG, LDL-C, and Apo B, rem arkably low er level of Apo AⅠ / Apo B, and higher levels of HDL-C,LP( a), and BU N as com pared with the non-affected group and the control group. The differences were statistically significant. The affected group in FH pedigrees had significantly higher levels of LDL-C and Apo B, higher levels of TC and Apo AⅠ/ Apo B, and significantly low er level of TAG as com pared with the affected group in FCH L pedigrees. Conclusion In addition to com m only used indexes TC,TAG, and LDL-C, the Apo B level and the ratio of Apo AⅠ/ Apo B are potential indexes for the differential diagnosis betw een FH and FCH L.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2016年第5期671-675,共5页 Journal of Shanghai Jiao tong University:Medical Science
基金 国家"十五"重大科技专项(2002BA711A08-17) 教育部科技基础平台建设(505015) 甘肃省自然科学研究基金(1308RJZA218 1302FKDA034)~~
关键词 家族性高胆固醇血症 家族性混合型高脂血症 载脂蛋白B 载脂蛋白AⅠ familial hypercholesterolemia familial combined hyperlipidemia apolipoprotein B apolipoprotein AⅠ
  • 相关文献

参考文献18

  • 1柴晓文.家族性高胆固醇血症[J].中国现代医生,2008,46(24):52-52. 被引量:3
  • 2Gohlberg AC, Hopkins PN, Toth PP, et al. Familial hypereholes~ terolemia: screening, diagnosis and management of pediatric and adah palients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia [J].. J Clin Lipid, 2011, 5(3) : SI -$8.
  • 3Cruz-Bautista I, Mehta R, Cabiedes J, et al. Determinants of VLDL composition and apn B-cnntaining particles in familial combined hyI~erlipidemia[J].Clin Chim Acta, 2015, 438: 160-165.
  • 4颜丽,朱江,何津祥,王广,何津春.家族性高胆固醇血症的临床诊断标准[J].兰州大学学报(医学版),2015,41(4):20-26. 被引量:6
  • 5Mateo-Gallego R, BaiIa-Rueda L, Mouratidou T, et al. Serum plant sterols as surrogate markers of dietary compliance in familial dyslipi- demias[J]. Clin Nutr, 2015, 34(3): 490-495.
  • 6Santilli F, Blardi P, Scapellato C, et al. Decreased plasma endoge- nous soluble RAGE, and enhanced adipokine secretion, oxidative stress and platelet/coagulative activation identify non-alcoholic fatty liver disease among patients with familial combined hyperlipidemia and/or metabolic syndrome[ J]. Vascul Pharmacol, 2015, 72: 16 - 24.
  • 7Brouwers MC, Konrad R J, van Himbergen TM, et al. Plasma prop- rotein eonvertase subtilisin kexln type 9 levels are related to markers of cholesterol synthesis in familial combined hyperlipidemia [ J ]. Nutr Metab Cardiovasc Dis, 2013, 23( 11 ) : 1115 -1121.
  • 8De Castro-Or6s I, Cenarro A, Tejedor MT, et al. Common genetic variants contribute to primary hypertriglyceridemia without diffe- rences between familial combined hyperlipidemia and isolated hyper- triglyceridemia[ J ]. Circ Cardiovase Genet, 2014, 7 (6):814 - 821.
  • 9许海燕,顼志敏,陆宗良.中国成人血脂异常防治指南(2007)概要与解读[J].中华老年心脑血管病杂志,2008,10(3):238-240. 被引量:151
  • 10Luo X, Yu C, Fu C, et al. Identification of the differentiallyexpressed genes associated with familial combined hyperlipidemia using bioinformatics analysis [J]. M ol Med Rep, 2015, 11 ( 6 ) : 4032 -4038.

二级参考文献46

  • 1陆宗良.脂质代谢异常的诊断与治疗[J].中国循环杂志,1993,8(3):183-186. 被引量:11
  • 2中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5234
  • 3[3]Umans Eckenhausen MAW,Ddcsche Jc,FIG,et al.Review analysis of detection of Familial Hypercholestemlemia for five years in Netherlands[J].Lancent,2001,357(1):165-168.
  • 4Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel Ⅲ guidelines. Circulation, 2004,110: 227-939.
  • 5Goldstein J L, Schrott H G, Hazzard W R, et al. Hyperlip- idemia in coronary heart disease: Ⅱ. genetic analysis of lipid levels in 176 families and delineation of a new inher- ited disorder, combined hyperlipidemia[J]. J Clin Invest, 1973, 52(7): 1544-1568.
  • 6Soutar A K, Naoumova R P. Mechanisms of disease: genetic causes of familial hypercholesterolemia[J]. NatClin Pract Cardiovasc Med, 2007, 4(4): 214-225.
  • 7Raal F, Panz V, Immelman A, et al. Elevated PCSK9 levels in untreated patients with heterozygous or homozy- gous familial hypercholesterolemia and the response to high-dose statin therapy[J]. J Am Heart Assoc, 2013, 2(2): e000028.
  • 8Nordestgaard B G, Chapman M J, Humphfies S E, et al. Familial hypercholesterolaemia is underdiagnosed and un- dertreated in the general population: guidance for clini- cians to prevent coronary heart disease, consensus state- ment of the European Atherosclerosis Society[J]. Eur Heart J, 2013, 34(45): 3478-3490.
  • 9Wu W F, Sun L Y, Pan X D, et al. Use of targeted exome sequencing in genetic diagnosis of Chinese familial hyper- cholesterolemia[J]. PLoS One, 2014, 9(4): e94697.
  • 10Hu M, Lan W, Lam C W, et al. Heterozygous familial hy- percholesterolemia in Hong Kong Chinese: study of 252 cases[J]. Int J Cardiol, 2013, 167(3): 762-767.

共引文献156

同被引文献21

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部